NPPB and heart failure: In the trial, patients with heart failure were selected based on specific criteria, including a left ventricular EF of less than or equal to 35%, NYHA functional classification class II to III, NT-proBNP concentration greater than or equal to 200 pg/ml, and a peak VO2 less than or equal to 75%.